Pharmaceutical Technology

MARCH 1, 2023

The drug candidate targets DNA-dependent protein kinase (DNA-PK). It is a new chemical entity. It was also under development for small cell lung cancer, rectal cancer and chronic lymphocytic leukemia (CLL). Merck overview Merck, a subsidiary of E. Merck KG, is a science and technology company.

Gene Editing 100

Gene Editing DNA Cosmetics Life Science 100

BioTech 365

SEPTEMBER 10, 2020

–(BUSINESS WIRE)–#Aldevron–Aldevron, a global leader in the production of plasmid DNA, mRNA and proteins, is now offering a GMP ribonucleoprotein (RNP) manufacturing service. FARGO, N.D.–(BUSINESS

Manufacturing 40

Manufacturing DNA Protein Production 40

XTalks

NOVEMBER 6, 2020

The Burnaby, BC-based company developed the oral DNA-based vaccine using its proprietary bacTRL Gene Therapy Platform, which uses genetically modified bifidobacteria as carriers of genetic vaccine elements on a DNA plasmid. Related: Red Meat Allergy Test Gets FDA Clearance. “We COVID-19 Clinical Trials.

Clinical Trials 75

Clinical Trials Clinical Trials Vaccine Vaccination 75

FDA Law Blog

MARCH 5, 2024

Gaulkin & Riëtte van Laack — As readers of this blog know, there is a lot of contention about the naming of alternative protein products (APPs), including both plant-based and cell-cultured alternatives for (traditional) animal products. By Sophia R. We’ve previously blogged about this ongoing battle here , here , here , and here.

Protein 59

Protein Production DNA Containment 59

XTalks

OCTOBER 28, 2021

First, while most cake mixes require eggs for structure, color and flavor, the Climate Hero Super Cake mix replaces approximately three eggs with the use of food tech startup Perfect Day’s animal-free milk protein. The resulting protein is then used to make plant-based versions of dairy-based foods. pic.twitter.com/8nWNA5Oya1.

Protein 98

Protein Packaging Packaging DNA 98

Roots Analysis

FEBRUARY 18, 2022

In the 20 th century, major research went into discovery of a therapeutic class with the primary purpose of interfering with the RNA expression linked to disease causing proteins, nowadays classified as oligonucleotides. Companies based in Asia-Pacific are increasingly undertaking initiatives in order to expand their manufacturing capacities.

Contract Manufacturing 52

Contract Manufacturing Manufacturing Drug Delivery Systems RNA 52

The Pharma Data

MARCH 30, 2021

Basel, March 30, 2021 — Novartis has obtained exclusive worldwide rights to develop and commercialize therapeutic applications for a library of Fibroblast Activation Protein (FAP) targeting agents including FAPI-46 and FAPI-74, through an assignment agreement with iTheranostics, Inc., an affiliate of SOFIE Biosciences, Inc.

Protein 52

Protein Licensing Licensing Containment 52

The Pharma Data

DECEMBER 23, 2020

” Dr. Stanley Plotkin , Professor Emeritus at The Wistar Institute, said, “INOVIO’s DNA vaccine appeared to be quite safe with few significant reactions but yet induced both antibody and T cell responses to SARS-CoV-2.” . PLYMOUTH MEETING, Pa. , PLYMOUTH MEETING, Pa. , mg and 2.0

DNA 40

DNA Vaccination Vaccine Immune Response 40

BioTech 365

OCTOBER 14, 2021

Flerie Invest AB leads $52m acquisition of Swedish Biopharma Facility from Charles River Flerie Invest AB leads $52m acquisition of Swedish Biopharma Facility from Charles River Major expansion of DNA, RNA, protein and advanced therapy R&D and GMP-manufacture STOCKHOLM, Sweden, … Continue reading →

RNA 40

RNA DNA Protein Manufacturing 40

The Pharma Data

DECEMBER 20, 2020

SN14 works by targeting the coronavirus’ nucleocapsid and spike proteins to prevent viral replication using the company’s ImmunoBody DNA vaccine technology. In October, Scancell signed a manufacturing deal for SN14 with Cobra Biologics, a Cognate BioServices subsidiary, ahead of a planned phase 1 trial in 2021.

Clinical Trials 52

Clinical Trials Clinical Trials Pharma Companies Vaccine 52

FDA Law Blog

DECEMBER 8, 2022

labeling of major food allergens in bulk foods, dietary supplements, protein-free ingredients, and foods produced through genetic engineering); and. 1, 2023; The applicability of food allergen labeling requirements to specific products (e.g., Other technical labeling matters. 1, 2023, sesame.

Genetic Engineering 59

Genetic Engineering Containment Cosmetics Protein 59

Delveinsight

AUGUST 6, 2020

The Indian company informed that the DNA vaccine was well tolerated in the first stage of the adaptive phase 1/2 trial. ZyCoV-D is designed to introduce DNA that encodes for a viral protein into human cells. By ordering human cells to make the protein, ZyCoV-D could cause an immune response against the coronavirus.

Allergies 53

Allergies Vaccine Vaccination Gene Therapy 53

Roots Analysis

FEBRUARY 27, 2024

The firm also has the right to obtain exclusive licenses to the Affimer proteins for clinical development and commercialization. What are Affimers : Affimers are small proteins that target and bind molecules on cellular surfaces in a manner analogous to monoclonal antibodies.

Antibody 52

Antibody Licensing Licensing Contract Manufacturing 52

Delveinsight

DECEMBER 31, 2020

A protein called ENPP1, which coats cancer cells, impedes warning signals of tumor formation before they can reach immune cells, the researchers elucidated in a study published in the journal Cancer Discovery. The over-expression of the protein rendered otherwise treatment-sensitive tumors resistant to the immuno-oncology agents.

DNA 52

DNA Protein Drugs Production 52

The Pharma Data

OCTOBER 18, 2020

(NASDAQ:CDXC) today highlighted a new study published in The European Molecular Biology Organization Journal looking at the effect of nicotinamide riboside (NR) on maintaining telomeres, the protective regions at the end of DNA strands. Telomeres are “caps” at the end of chromosomes that protect DNA from getting worn away as cells replicate.

DNA 52

DNA Scientist Genetic Disease Research 52

Roots Analysis

AUGUST 12, 2024

Molecular diagnostic tests refer to tests intended to detect specific sequences in human genomic samples, such as DNA or RNA, in order to diagnose a particular disease. The common types of molecular diagnostic tests include PCR, RT-PCR, DNA microarrays and next generation sequencing tests. What are Molecular Diagnostic Tests?

Genetics 40

Genetics Gene Expression RNA DNA 40

XTalks

DECEMBER 27, 2022

The pharma company will expand its manufacturing capacity for commercial scale vector production for oncology treatment. Then, the cells translate the DNA sequence of the gene and secrete high amounts of the protein interferon alfa-2b. This protein is naturally occurring in the human body and the body uses it to fight cancer.

Gene Therapy 52

Gene Therapy FDA Approval Gene Clinical Trials 52

Roots Analysis

JANUARY 21, 2024

Over time, the evolution of recombinant DNA technology and advances in conjugation techniques, have enabled researchers to significantly improve the bioconjugation process. In fact, next generation conjugation technologies use artificially integrated lysine / cysteine residues in order to improve the DAR of the resulting conjugate.

Antibody 40

Antibody Recombinant DNA Technology Drugs Marketing 40

The Pharma Data

JANUARY 27, 2021

PGRN is a complex and highly conserved protein. The gene therapy utilizes an AAV1 viral vector to deliver a modified DNA encoding the GRN gene to a patient’s cells. The mechanism by which PGRN deficiency results in FTD is uncertain, but increasing evidence points to PGRN’s role in lysosomal function.

Gene Therapy 52

Gene Therapy Gene Clinical Trials Clinical Trials 52

The Pharma Data

OCTOBER 14, 2020

Assistant Professor of Medical Sciences at Columbia University Vagelos College of Physicians and Surgeons, is designed to generate DNA aptamer-based anti-idiotypes to selected monoclonal antibodies identified in Dr. Ilya Trakht’s study. The study led by Dr. Sergei Rudchenko, Ph.D., About TNX-1800. 1 Noyce RS, et al. 2018) PLoS One.

Vaccine 40

Vaccine Vaccination Development Medicine 40

The Pharma Data

SEPTEMBER 1, 2020

About antigen testing An antigen test detects proteins which are structural or functional components of a pathogen and are thus very specific to that pathogen. Results are ready in only 15 minutes. Ensuring the supply of our existing medicines and diagnostics to patients around the world under exceptional conditions.

In-Vitro 52

In-Vitro Antibody Medicine Clinical Trials 52

Roots Analysis

JANUARY 28, 2024

Some of the areas she has worked on include protein design and engineering, metabolomics services, bioavailability enhancement technologies and services, plasmid DNA manufacturing, NAMPT inhibitors, and big data analytics in healthcare domain.

Big Data 40

Big Data Medicine Marketing Clinical Trials 40

Roots Analysis

SEPTEMBER 9, 2024

Over the years, pharmaceutical companies have shifted their priorities from traditional interventions towards more advanced pharmacological strategies, such as protein therapeutics. Further, $400 billion is the anticipated sales of protein-based therapeutics in 2023. The mRNA is then translated into to form functional proteins.

Protein 40

Protein Gene Production DNA 40

Pharmaceutical Technology

FEBRUARY 3, 2023

Since HIV integrates with the DNA, eliminating the virus from the body is very difficult, explains David Montefiori, PhD, director of the Laboratory for AIDS Vaccine Research and Development at Duke University in Durham, North Carolina. mRNA vaccines can be made and modified quickly compared to protein subunit vaccines, says Montefiore.

Vaccine 293

Vaccine Vaccination Antibody Trials 293

Roots Analysis

OCTOBER 16, 2023

DNA cloning refers to the process of generating multiple copies of a particular DNA segment. DNA and Gene Cloning involves the isolation of a DNA sequence of any species ( often a gene ) and its insertion into a vector to enable growth without any alteration in the original DNA sequence.

DNA 40

DNA Gene Protein In-Vitro 40

pharmaphorum

JANUARY 29, 2021

‘Cutting edge’ is, for once, a truly apt description when it comes to gene editing – both because the field is pushing medicine into areas we might never have dreamed possible, and because these technologies involve literally cutting DNA at a specific point in the genome. There is also a shortage of manufacturing sites.”.

Gene Editing 145

Gene Editing Gene Gene Therapy In-Vivo 145

Cloudbyz

MARCH 6, 2024

This shift signifies not just a change in the way drugs are manufactured and administered, but also a fundamental transformation in the approach to treating diseases at their root cause. Understanding Biologics: Biologics are a class of therapeutic agents derived from living organisms, such as cells, tissues, or proteins.

Gene 99

Gene Immune Response Manufacturing Gene Therapy 99

pharmaphorum

MAY 11, 2021

Called eRNA for short, this class of medicines is programmable and can continuously express therapeutic proteins inside the body. The technology is designed to replace antibodies, which have become standard therapy in many diseases but are complicated and expensive to manufacture.

RNA 98

RNA Drugs Protein Immune Response 98

Pharmaceutical Technology

MAY 24, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Protein 130

Protein Antibody Medicine Development 130

Pharmaceutical Technology

FEBRUARY 14, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely. The most common heteroatoms are nitrogen (N), oxygen (O) and sulphur (S).

Antibody 130

Antibody Hormones DNA Licensing 130

XTalks

OCTOBER 26, 2023

The Flu versus COVID-19: Virology and Vaccines SARS-CoV-2 versus Influenza Virology Viruses contain genetic material that can either be RNA or DNA. This means COVID-19 can quickly produce viral proteins once inside the host cell, which may make its replication cycle faster than influenza. remains the dominant variant.

Vaccine 105

Vaccine Vaccination RNA Manufacturing 105

Roots Analysis

OCTOBER 22, 2023

Coding RNAs include messenger RNA (mRNA) and short interfering RNA (siRNA), which encode proteins and silence gene expression, respectively. ASOs are short single-stranded nucleotides that bind to specific messenger RNAs and prevent the production of a particular protein.

RNA 40

RNA Protein Genetics Gene Expression 40

XTalks

MARCH 10, 2021

The T cell test from Adaptive Biotechnologies detects DNA sequences from T cells, specifically sequencing T cell receptors (TCR) on CD8+ T cells. Cue Health is planning to manufacture more than 100,000 tests per day by the summer. 3. Quidel QuickVue At-Home COVID-19 Antigen Test.

Protein 98

Protein RNA Antibody Production 98

XTalks

DECEMBER 13, 2023

The CRISPR system is dubbed to be molecular “scissors” that can cut out parts of genes that are abnormal, deactivating or replacing them with new strands of normal DNA. Obenshain said the company will book revenue when the final product is infused, and that the product manufacturing could take 70 to 105 days.

Gene Therapy 98

Gene Therapy Gene FDA Approval In-Vivo 98

Pharmaceutical Technology

JUNE 8, 2023

GenScript ProBio has collaborated with the New York Blood Center Enterprises’ business unit, called Comprehensive Cell Solutions (CCS), to accelerate the development and manufacture of cell and gene therapies. The core objective of the collaboration is to make the therapies affordable and accessible to patients.

Gene Therapy 130

Gene Therapy Gene Development Antibody 130

Pharmaceutical Technology

MAY 8, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely. These viruses carry the genetic information to synthesise an RNA-dependent RNA polymerase.

RNA 240

RNA Genetics Vaccination Vaccine 240

The Pharma Data

OCTOBER 14, 2020

The AOP Orphan Group manufactures 80% of its drugs in Europe and has more than 20 subsidiaries and representative offices across the whole of Europe as well as in the United Arab Emirates and Israel. The funds will be used to bring Ori’s innovative manufacturing platform to the market. million if certain project milestones are met.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing In-Vivo 52